These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 4834491

  • 1. Editorial: Factor VIII inhibitors.
    Deykin D.
    N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491
    [No Abstract] [Full Text] [Related]

  • 2. Activated prothrombin concentrate for patients with factor VIII inhibitors.
    Kurczynski EM, Penner JA.
    N Engl J Med; 1974 Jul 25; 291(4):164-7. PubMed ID: 4834485
    [No Abstract] [Full Text] [Related]

  • 3. Surgical care of patients with hereditary disorders of blood coagulation.
    Shulman NR.
    Mod Treat; 1968 Jan 25; 5(1):61-83. PubMed ID: 4870180
    [No Abstract] [Full Text] [Related]

  • 4. Therapeutic materials used in the treatment of coagulation defects.
    Smith JK, Bidwell E.
    Clin Haematol; 1979 Feb 25; 8(1):183-206. PubMed ID: 367662
    [No Abstract] [Full Text] [Related]

  • 5. Clinical use of human prothrombin complexes.
    Tullis JL, Melin M, Jurigian P.
    N Engl J Med; 1965 Sep 23; 273(13):667-74. PubMed ID: 5827030
    [No Abstract] [Full Text] [Related]

  • 6. Human prothrombin complex.
    N Engl J Med; 1965 Sep 23; 273(13):715-6. PubMed ID: 5827038
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical experience with the PPSB fraction in surgery].
    Frick U.
    Zentralbl Chir; 1972 Feb 05; 97(5):150-3. PubMed ID: 5020589
    [No Abstract] [Full Text] [Related]

  • 8. Surgery in haemophilic patients with inhibitors.
    Rodriguez-Merchan EC.
    Haemophilia; 2004 Sep 05; 10 Suppl 2():1-2. PubMed ID: 15385039
    [No Abstract] [Full Text] [Related]

  • 9. [Administration of a new prothrombin complex concentrate in patients treated with anticoagulants and in patients with liver diseases].
    Fischer M, Falkensammer C, Gauss P, Korp W, Kubiena K, Neubert J, Schnack H, Weissmann A.
    Med Welt; 1973 Nov 30; 24(48):1899-902. PubMed ID: 4774863
    [No Abstract] [Full Text] [Related]

  • 10. Prothrombin complex concentrates: clinical use.
    Menache D.
    Ann N Y Acad Sci; 1981 Nov 30; 370():747-56. PubMed ID: 6791551
    [No Abstract] [Full Text] [Related]

  • 11. [6-years' experience with the clinical use of the hemostatic preparation, PPSB].
    Koniukhov SG, Saltykova ZA, Tarasova LN.
    Probl Gematol Pereliv Krovi; 1977 Aug 30; 22(8):37-40. PubMed ID: 928338
    [No Abstract] [Full Text] [Related]

  • 12. [Blood plasma fractions for the management of coagulation disorders: 3. The P.P.S.B. fraction].
    Richter K, Klingenberg K, Reinecke D.
    Z Gesamte Inn Med; 1968 Jan 01; 23(1):18-21. PubMed ID: 5662427
    [No Abstract] [Full Text] [Related]

  • 13. Letter: Factor VIII inhibitor following surgery for epidural hemorrhage in hemophilia: successful therapy with a concentrate containing factors II, VII, IX, and X.
    Goodknight SH, Common HH, Lovrein EW.
    J Pediatr; 1976 Feb 01; 88(2):356-7. PubMed ID: 1249702
    [No Abstract] [Full Text] [Related]

  • 14. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
    Fischer M.
    Wien Klin Wochenschr; 1983 Feb 04; 95(3):82-5. PubMed ID: 6858171
    [Abstract] [Full Text] [Related]

  • 15. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR, Kevy SV.
    Pediatrics; 1978 Nov 04; 62(5):767-74. PubMed ID: 724319
    [Abstract] [Full Text] [Related]

  • 16. [Blood coagulation disorders caused by abnormal blood coagulation factors].
    Fiedler H.
    Z Arztl Fortbild (Jena); 1972 Jul 01; 66(13):692-8. PubMed ID: 4636972
    [No Abstract] [Full Text] [Related]

  • 17. [Substitution therapy of hemorrhagic diseases].
    Haupt H.
    Anasthesiol Intensivmed Prax; 1975 Oct 01; 11(1):137-44. PubMed ID: 1225069
    [No Abstract] [Full Text] [Related]

  • 18. [On the therapy of bleeding tendency due to vitamin K deficiency and dysfunction of the liver during the first year of life. (Combined treatment with a concentrate of factors II, VII, IX and X and heparin) (author's transl)].
    Göbel U, Petrich C.
    Monatsschr Kinderheilkd (1902); 1974 Feb 01; 122(2):60-4. PubMed ID: 4594807
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic approaches to factor X deficiency with emphasis on the use of a new clotting-factor concentrate (Konyne).
    O'Leary DS, Ruymann FB, Conrad ME.
    J Lab Clin Med; 1971 Jan 01; 77(1):23-32. PubMed ID: 5540427
    [No Abstract] [Full Text] [Related]

  • 20. Editorial: Treatment of hemophilic children who have factor VIII inhibitors.
    Pearson HA.
    J Pediatr; 1976 Feb 01; 88(2):367-8. PubMed ID: 1249715
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.